Chemical activators of OTTMUSG00000005523 can initiate various intracellular signaling pathways that result in the phosphorylation and subsequent activation of the protein. Forskolin, by activating adenylyl cyclase, leads to an increase in cyclic AMP (cAMP) levels within the cell. This surge in cAMP activates protein kinase A (PKA), which then phosphorylates target proteins including OTTMUSG00000005523. Similar effects are observed with the action of Epinephrine and Isoproterenol, both of which bind to their respective adrenergic receptors, thereby stimulating adenylyl cyclase activity and enhancing cAMP production. The elevated cAMP, in turn, activates PKA which can phosphorylate and activate OTTMUSG00000005523. Ionomycin raises intracellular calcium levels, potentially activating calcium-dependent protein kinases that can also phosphorylate this protein. Activation of protein kinase C (PKC) through the application of Phorbol 12-myristate 13-acetate (PMA) is another pathway that leads to phosphorylation events. Anisomycin's activation of stress-activated protein kinases (SAPKs) similarly can result in the phosphorylation of OTTMUSG00000005523.
In another set of pathways, the focus shifts to the inhibition of dephosphorylation processes. Okadaic Acid and Calyculin A inhibit protein phosphatases 1 and 2A, which normally act to remove phosphate groups from proteins, thereby maintaining OTTMUSG00000005523 in a phosphorylated state. Sildenafil, by inhibiting phosphodiesterase 5 (PDE5), causes an increase in cGMP levels, which can activate protein kinases that phosphorylate OTTMUSG00000005523. IBMX, as a non-selective inhibitor of phosphodiesterases, elevates both cAMP and cGMP levels, and the resulting activation of PKA can lead to the phosphorylation of OTTMUSG00000005523. The use of 8-Br-cAMP, a cAMP analog, directly activates PKA, leading to phosphorylation of the protein. Lastly, H-89, despite being a PKA inhibitor, can lead to the activation of alternative pathways that result in the phosphorylation and activation of OTTMUSG00000005523 due to disruption of regulatory feedback loops. These pathways collectively ensure that OTTMUSG00000005523 can be activated through multiple biochemical routes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to and activates adrenergic receptors, which leads to the activation of adenylyl cyclase and increased cAMP synthesis. Subsequently, cAMP activates PKA, which can phosphorylate and activate OTTMUSG00000005523. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent protein kinases. These kinases can phosphorylate and activate OTTMUSG00000005523. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate and activate various proteins. Activation of PKC could lead to the phosphorylation and subsequent activation of OTTMUSG00000005523. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which can lead to the phosphorylation and activation of OTTMUSG00000005523. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is an inhibitor of protein phosphatases 1 and 2A, leading to sustained phosphorylation states of proteins. Inhibition of protein dephosphorylation could keep OTTMUSG00000005523 in an activated phosphorylated state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like Okadaic Acid, inhibits protein phosphatases, potentially maintaining OTTMUSG00000005523 in a phosphorylated and active state. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, increasing levels of cAMP and cGMP within the cell. Elevated cAMP levels can activate PKA, which may phosphorylate and activate OTTMUSG00000005523. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. Activated PKA can phosphorylate and thereby activate OTTMUSG00000005523. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a protein kinase A inhibitor. However, paradoxically, it can also serve to activate certain proteins indirectly by disrupting regulatory feedback loops. In certain cellular contexts, this can lead to the activation of alternative pathways that may result in the phosphorylation and activation of OTTMUSG00000005523. | ||||||